Advertisement
Screener

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) Proceeds from Lines of Credit

1.9 / 5 stars · 45/118 Roast Me

NATURAL ALTERNATIVES INTERNATIONAL INC Proceeds from Lines of Credit

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) reported Proceeds from Lines of Credit of $1.60 million for the 6-month period ending 2024-12-31, per its 10-Q filed 2025-02-14.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromLinesOfCredit · last filed 2025-02-14

  • NATURAL ALTERNATIVES INTERNATIONAL INC proceeds from lines of credit for the quarter ending 2024-12-31 was -$400.00K.
  • NATURAL ALTERNATIVES INTERNATIONAL INC proceeds from lines of credit for the quarter ending 2024-09-30 was $2.00M.
  • NATURAL ALTERNATIVES INTERNATIONAL INC proceeds from lines of credit for the quarter ending 2024-06-30 was $3.40M.
  • NATURAL ALTERNATIVES INTERNATIONAL INC proceeds from lines of credit for the quarter ending 2024-03-31 was $0.00.
  • NATURAL ALTERNATIVES INTERNATIONAL INC proceeds from lines of credit for fiscal 2024 was $3.40M.
  • NATURAL ALTERNATIVES INTERNATIONAL INC proceeds from lines of credit for fiscal 2023 was $0.00.
  • NATURAL ALTERNATIVES INTERNATIONAL INC proceeds from lines of credit for fiscal 2020 was $10.00M.
Period endProceeds from Lines of Credit 3 monthProceeds from Lines of Credit 6 monthProceeds from Lines of Credit 9 monthProceeds from Lines of Credit 12 month
2024-12-31-$400.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14
$1.60M
10-Q · filed 2025-02-14
$5.00M
derived: sum of 3 quarters · filed 2025-02-14
$5.00M
derived: sum of 4 quarters · filed 2025-02-14
2024-09-30$2.00M
10-Q · filed 2024-11-13
$5.40M
derived: sum of 2 quarters · filed 2024-11-13
$5.40M
derived: sum of 3 quarters · filed 2024-11-13
$5.40M
derived: sum of 4 quarters · filed 2025-02-14
2024-06-30$3.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27
$3.40M
derived: sum of 2 quarters · filed 2024-09-27
$3.40M
derived: sum of 3 quarters · filed 2025-02-14
$3.40M
10-K · filed 2024-09-27
2024-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14
$0.00
derived: sum of 2 quarters · filed 2025-02-14
$0.00
10-Q · filed 2024-05-14
-$9.10M
derived: sum of 4 quarters · filed 2025-02-14
2023-12-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14
$0.00
10-Q · filed 2025-02-14
-$9.10M
derived: sum of 3 quarters · filed 2025-02-14
2023-09-30$0.00
10-Q · filed 2024-11-13
-$9.10M
derived: sum of 2 quarters · filed 2024-11-13
2023-06-30-$9.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27
$0.00
10-K · filed 2024-09-27
2023-03-31$9.10M
10-Q · filed 2024-05-14
2022-09-30$3.40M
10-Q · filed 2023-11-09
2022-03-31$0.00
10-Q · filed 2023-05-15
2020-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-21
$10.00M
10-K · filed 2020-09-21
2020-03-31$10.00M
10-Q · filed 2020-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANNATECH INC (MTEX)United States$0.014B
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87